Suplatast tosylate
CAS: 94055-76-2
Ref. 3D-FS27977
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar |
Informação sobre produto
- [3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethylsulfonium 4-methylbenzenesulfonate(±)-[2-[4-(3-Ethoxy-2-hydroxy propoxy)phenylcarbamoyl]ethyl]dimethylsulfonium p-toluenesulfonateIPD 1151T
- (2-(4-(3-Ethoxy-2-Hydroxypropoxy)Phenylcarbamoyl)Ethyl)Dimethylsulfonium P-Toluenesulfonate
- (3-{[4-(3-Ethoxy-2-Hydroxypropoxy)Phenyl]Amino}-3-Oxopropyl)(Dimethyl)Sulfonium 4-Methylbenzenesulfonate
- Ipd 1151T
- Sulfonium, [3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethyl-, 4-methylbenzenesulfonate (1:1)
- Sulfonium, [3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)
Suplatast tosylate is an aldehyde-containing pentosan polysulfate sodium. It is a biocompatible polymer with a diameter of 400 nm and is used in the treatment of cancer. Suplatast tosylate has been shown to be effective against cervical cancer, which may be due to its ability to inhibit growth factor receptors. Suplatast tosylate also has anti-inflammatory properties and is used as an oral drug for the treatment of inflammatory diseases such as bladder inflammation or Crohn's disease. Suplatast tosylate can also be administered intravenously for the treatment of cancer or inflammatory diseases such as rheumatoid arthritis.
Propriedades químicas
Consulta técnica sobre: 3D-FS27977 Suplatast tosylate
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
